Preparation, Characterization, and Oral Bioavailability of Solid Dispersions of Cryptosporidium parvum Alternative Oxidase Inhibitors
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137025 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yongxiang Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricu…. Hauptthemen laut MEDLINE: Biological Availability, Cryptosporidium parvum, Solubility. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dongping Zeng, National Key R&D Program of China.
Abstract (Originalsprache)
The phenylpyrazole derivative 5-amino-3-[1-cyano-2-(3-phenyl-1H-pyrazol-4-yl) vinyl]-1-phenyl-1H-pyrazole-4-carbonitrile (LN002), which was screened out through high-throughput molecular docking for the AOX target, exhibits promising efficacy against Cryptosporidium. However, its poor water solubility limits its oral bioavailability and therapeutic utility. In this study, solid dispersion agents were prepared by using HP-β-CD and Soluplus® and characterized through differential scanning calorimetry, Fourier transform infrared, powder X-ray diffraction, and scanning electron microscopy. Physical and chemical characterization showed that the crystal morphology of LN002 transformed into an amorphous state, thus forming a solid dispersion of LN002. The solid dispersion prepared with an LN002/HP-β-CD/Soluplus® mass ratio of 1:3:9 (w/w/w) exhibited significantly increased solubility and cumulative dissolution. Meanwhile, LN002 SDs showed good preservation stability under accelerated conditions of 25 °C and 75% relative humidity. The complexation of LN002 with HP-β-CD and Soluplus® significantly improved water solubility, pharmacological properties, absorption, and bioavailability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
- National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, Guangzhou 510642, China.
ORCID-Profile: Dongping Zeng
Förderung
- Dongping Zeng
- National Key R&D Program of China
Zitieren
APA
Zhang, Y., Ma, M., Yang, J., Qiu, X., Xin, L., Lu, Y., Huang, H., Zeng, Z., & Zeng, D. (2024). Preparation, Characterization, and Oral Bioavailability of Solid Dispersions of Cryptosporidium parvum Alternative Oxidase Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137025
Vancouver
Zhang Y, Ma M, Yang J, Qiu X, Xin L, Lu Y, et al. Preparation, Characterization, and Oral Bioavailability of Solid Dispersions of Cryptosporidium parvum Alternative Oxidase Inhibitors. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137025
BibTeX
@article{Zhang2024,
author = {Zhang, Yongxiang and Ma, Minglang and Yang, Jinyu and Qiu, Xiaotong and Xin, Lin and Lu, Yixing and Huang, Huiguo and Zeng, Zhenling and Zeng, Dongping},
title = {Preparation, Characterization, and Oral Bioavailability of Solid Dispersions of Cryptosporidium parvum Alternative Oxidase Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137025}
}
EUVIMED